Biblio | neuro.ulaval.ca

Export 95 results:

EndNote XML

Filters: Author is Langlois, Mélanie [Clear All Filters]

2020

Gan-Or, iv Z, Rao T, Leveille E, Degroot C, Chouinard S, Cicchetti F, Dagher A, Das S, Desautels A, Drouin-Ouellet J, Durcan T, Gagnon J-F, Genge A, Karamchandani J, Lafontaine A-L, Sun SLai Wing, Langlois M, Lévesque M, Melmed C, Panisset M, Parent M, Poline J-B, Postuma RB, Pourcher E, Rouleau GA, Sharp M, Monchi O, Dupré N, Fon EA. The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository. J Parkinsons Dis. 2020;10(1):301-313.

2019

Giguère-Rancourt A, Plourde M, Doiron M, Langlois M, Dupré N, Simard M. Goal management training ® home-based approach for mild cognitive impairment in Parkinson's disease: a multiple baseline case report. Neurocase. 2019;:1-11.

Lamontagne-Proulx J, St-Amour I, Labib R, Pilon J, Denis HL, Cloutier N, Roux-Dalvai F, Vincent AT, Mason SL, Williams-Gray C, Duchez A-C, Droit A, Lacroix S, Dupré N, Langlois M, Chouinard S, Panisset M, Barker RA, Boilard E, Cicchetti F. Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease. Neurobiol Dis. 2019;124:163-175.

Alcalay RN, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu RYJ, Ruskey JA, Leblond CS, Ambalavanan A, Laurent SB, Spiegelman D, Dionne-Laporte A, Liong C, Levy OA, Fahn S, Waters C, Kuo S-H, Chung WK, Ford B, Marder KS, Kang UJung, Hassin-Baer S, Greenbaum L, Trempe J-F, Wolf P, Oliva P, Zhang XKate, Clark LN, Langlois M, Dion PA, Fon EA, Dupré N, Rouleau GA, Gan-Or, iv Z. SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease. Mov Disord. 2019;34(4):526-535.

2017

Doiron M, Langlois M, Dupré N, Simard M. The influence of vascular risk factors on cognitive function in early Parkinson's disease. Int J Geriatr Psychiatry. 2017;.

Doiron M, Dupré N, Langlois M, Provencher P, Simard M. Smoking history is associated to cognitive impairment in Parkinson's disease. Aging Ment Health. 2017;21(3):322-326.

2016

Ross JP, Dupré N, Dauvilliers Y, Strong S, Ambalavanan A, Spiegelman D, Dionne-Laporte A, Pourcher E, Langlois M, Boivin M, Leblond CS, Dion PA, Rouleau GA, Gan-Or, iv Z. Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's disease. Neurobiol Aging. 2016;45:212.e13-212.e17.

Tremblay C, Monetta L, Langlois M, Schneider C. Intermittent Theta-Burst Stimulation of the Right Dorsolateral Prefrontal Cortex to Promote Metaphor Comprehension in Parkinson Disease: A Case Study. Arch Phys Med Rehabil. 2016;97(1):74-83.

Gan-Or, iv Z, Mohsin N, Girard SL, Montplaisir JY, Ambalavanan A, Strong S, Mallett V, Laurent SB, Bourassa CV, Boivin M, Langlois M, Arnulf I, Högl B, Frauscher B, Monaca C, Desautels A, Gagnon J-F, Postuma RB, Dion PA, Dauvilliers Y, Dupré N, Alcalay RN, Rouleau GA. The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder. Neurobiol Aging. 2016;43:180.e7-180.e13.

2014

Sauvageau VMartel, Macoir J, Langlois M, Prud'homme M, Cantin L, Roy J-P. Changes in vowel articulation with subthalamic nucleus deep brain stimulation in dysarthric speakers with Parkinson's disease. Parkinsons Dis. 2014;2014:487035.

Langlois M, Doré M-C, Laforce, Jr R. Thirty Days without a Bite: Wernicke's Encephalopathy in a Patient with Paranoid Schizophrenia. J Neurol Disord. 2014;2:182.

2013

Macoir J, Fossard M, Merette C, Langlois M, Chantal S, Auclair-Ouellet N. The role of basal ganglia in language production: evidence from Parkinson's disease. J Parkinsons Dis. 2013;3(3):393-7.